List of Excipients in API naloxone
✉ Email this page to a colleague
Excipients in NDA-approved (novel) drugs containing naloxone
| Company | Tradename | Ingredient | NDC | Excipient | Potential Generic Entry |
|---|---|---|---|---|---|
| Summit Biosciences Inc | NALOXONE | naloxone | 43674-003 | GLYCERIN | |
| Summit Biosciences Inc | NALOXONE | naloxone | 43674-003 | HYDROCHLORIC ACID | |
| Summit Biosciences Inc | NALOXONE | naloxone | 43674-003 | SODIUM HYDROXIDE | |
| Summit Biosciences Inc | NALOXONE | naloxone | 43674-003 | TRISODIUM CITRATE DIHYDRATE | |
| Summit Biosciences Inc | NALOXONE | naloxone | 43674-003 | WATER | |
| Hikma Specialty USA Inc | KLOXXADO | naloxone hcl | 59467-679 | ALCOHOL | |
| Hikma Specialty USA Inc | KLOXXADO | naloxone hcl | 59467-679 | EDETATE DISODIUM | |
| >Company | >Tradename | >Ingredient | >NDC | >Excipient | >Potential Generic Entry |
Excipients in ANDA-approved (generic) drugs containing naloxone
Detailed excipient profiles for naloxone
Excipient focus: ALCOHOL
naloxone drug variants containing ALCOHOL
| Company | Ingredient | NDC |
|---|---|---|
| Hikma Specialty USA Inc | naloxone hcl | 59467-679 |
| >Company | >Ingredient | >NDC |
naloxone drug variants not containing ALCOHOL
Excipient focus: BENZALKONIUM CHLORIDE
naloxone drug variants containing BENZALKONIUM CHLORIDE
naloxone drug variants not containing BENZALKONIUM CHLORIDE
Excipient focus: EDETATE DISODIUM
naloxone drug variants containing EDETATE DISODIUM
naloxone drug variants not containing EDETATE DISODIUM
Excipient focus: GLYCERIN
naloxone drug variants containing GLYCERIN
| Company | Ingredient | NDC |
|---|---|---|
| Summit Biosciences Inc | naloxone | 43674-003 |
| Summit Biosciences Inc | naloxone hydrochloride | 43674-004 |
| >Company | >Ingredient | >NDC |
naloxone drug variants not containing GLYCERIN
Excipient focus: HYDROCHLORIC ACID
naloxone drug variants containing HYDROCHLORIC ACID
naloxone drug variants not containing HYDROCHLORIC ACID
| Company | Ingredient | NDC |
|---|---|---|
| Lake Erie Medical DBA Quality Care Products LLC | naloxone hydrochloride | 55700-457 |
| Mylan Institutional LLC | naloxone hydrochloride | 67457-992 |
| International Medication Systems Ltd | naloxone hydrochloride | 76329-3669 |
| >Company | >Ingredient | >NDC |
Excipient focus: METHYLPARABEN
naloxone drug variants containing METHYLPARABEN
naloxone drug variants not containing METHYLPARABEN
Excipient focus: NITROGEN
naloxone drug variants containing NITROGEN
| Company | Ingredient | NDC |
|---|---|---|
| Dr Reddy's Laboratories Inc | naloxone hydrochloride | 43598-750 |
| HF Acquisition Co LLC DBA HealthFirst | naloxone hydrochloride | 51662-1529 |
| Meitheal Pharmaceuticals Inc | naloxone hydrochloride | 71288-814 |
| >Company | >Ingredient | >NDC |
naloxone drug variants not containing NITROGEN
Excipient focus: PROPYLENE GLYCOL
naloxone drug variants containing PROPYLENE GLYCOL
| Company | Ingredient | NDC |
|---|---|---|
| Hikma Specialty USA Inc | naloxone hcl | 59467-679 |
| >Company | >Ingredient | >NDC |
naloxone drug variants not containing PROPYLENE GLYCOL
Excipient focus: PROPYLPARABEN
naloxone drug variants containing PROPYLPARABEN
naloxone drug variants not containing PROPYLPARABEN
Excipient focus: SODIUM CHLORIDE
naloxone drug variants containing SODIUM CHLORIDE
naloxone drug variants not containing SODIUM CHLORIDE
| Company | Ingredient | NDC |
|---|---|---|
| Summit Biosciences Inc | naloxone | 43674-003 |
| Hikma Specialty USA Inc | naloxone hcl | 59467-679 |
| Summit Biosciences Inc | naloxone hydrochloride | 43674-004 |
| >Company | >Ingredient | >NDC |
Excipient focus: SODIUM HYDROXIDE
naloxone drug variants containing SODIUM HYDROXIDE
naloxone drug variants not containing SODIUM HYDROXIDE
Excipient focus: TRISODIUM CITRATE DIHYDRATE
naloxone drug variants containing TRISODIUM CITRATE DIHYDRATE
| Company | Ingredient | NDC |
|---|---|---|
| Summit Biosciences Inc | naloxone | 43674-003 |
| Summit Biosciences Inc | naloxone hydrochloride | 43674-004 |
| Harm Reduction Therapeutics Inc | naloxone hydrochloride | 82954-0100 |
| >Company | >Ingredient | >NDC |
naloxone drug variants not containing TRISODIUM CITRATE DIHYDRATE
Excipient focus: WATER
naloxone drug variants containing WATER
naloxone drug variants not containing WATER
Make Better Decisions: Try a trial or see plans & pricing
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.
ISSN: 2162-2639
Privacy and Cookies
Terms & Conditions
Site Map
DrugPatentWatch Alternatives
LOE / Generic Entry Opportunies 2026 - 2027
NCE-1 Patent Challenge Dates 2026 - 2027
Friedman, Yali. "DrugPatentWatch" DrugPatentWatch, thinkBiotech, 2026, www.DrugPatentWatch.com.
See Primary Research Papers Citing DrugPatentWatch